Inovio Pharmaceuticals, Inc. (INO)

2.06 -0.07 (-3.29%) USD  |  NASDAQ  |  Dec 12, 16:00
2.10 +0.04 (+1.94%) After-Hours: 20:00
More

Inovio Pharmaceuticals Research and Development Expense (Annual): 77.22M for Dec. 31, 2024

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for INO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Agenus, Inc. 155.53M
Arcturus Therapeutics Holdings, Inc. 124.69M
Capricor Therapeutics, Inc. 49.19M
AIM ImmunoTech, Inc. 6.149M
Protalix Biotherapeutics, Inc. 12.97M